triamcinolone acetonide has been researched along with Ocular Hypertension in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (5.00) | 18.2507 |
2000's | 54 (54.00) | 29.6817 |
2010's | 32 (32.00) | 24.3611 |
2020's | 9 (9.00) | 2.80 |
Authors | Studies |
---|---|
Lee, CK; Lee, TH; Nam, JG | 1 |
Badrinarayanan, L; George, R; Isaac, N; Rishi, E; Rishi, P | 1 |
Badrinarayanan, L; Chitipothu, S; George, RJ; Nagarajan, H; Rishi, E; Rishi, P | 1 |
Abdin, AD; Löw, U; Munteanu, C; Seitz, B; Wykrota, AA | 1 |
Bello, N; Chiang, A; Garg, S; Goodman, J; Kuley, B; Murphy, J; Obeid, A; Pancholy, M; Regillo, C; Storey, PP; Wibbelsman, TD | 1 |
Hsieh, YT; Hsu, WC; Yang, YH | 1 |
Bello, N; Chiang, A; Dunn, JP; Fineman, MS; Garg, S; Gupta, OP; Kaiser, RS; Kuley, B; Maguire, JI; Mehta, S; Obeid, A; Pancholy, M; Park, CH; Regillo, C; Sharpe, J; Spirn, MJ; Storey, PP; Vander, JF; Wibbelsman, TD; Zhang, QE | 1 |
Borkar, D; Goodman, J; Obeid, A; Pancholy, M; Regillo, C; Storey, PP; Su, D | 1 |
Abdullatif, AM; Fouad, HM; Helmy, YAH; Macky, TA; Mansour, K; Saady, AM | 1 |
Baser, EF; Gülhan, C; Öztürk, B; Seymenoğlu, G | 1 |
Arévalo, FA; Arévalo, JF; Fernández, CF; García, RA; Mendoza, AJ | 1 |
Durukan, AH; Erdurman, FC; Gokce, G; Sobaci, G | 1 |
den Hollander, AI; Hogewind, BF; Hoyng, CB; Micheal, S; Schoenmaker-Koller, FE | 1 |
Cheng, YH; Chiou, SH; Chiu, AW; Hung, KH; Ku, RY; Lee, CJ; Liu, CJ; Tsai, TH | 1 |
Clark, B; Craig, JE; Fitzgerald, JT; Goldberg, I; Mills, RA; Ridge, B; Saunders, L; White, AJ | 1 |
Aref, AA; Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
Agard, E; Dot, C; El Chehab, H; Russo, A | 1 |
Chan, LW; Hsieh, YT; Hsu, WC | 1 |
Candia, O; Danias, J; Fridman, G; Gerometta, R; Rybkin, I | 1 |
Atchison, EA; Bakri, SJ | 1 |
Chang, SH; Hsieh, YT; Yang, CM | 1 |
Eke, T; Hurst, JR; Jain, S; Thompson, JR | 1 |
Chen, KC; Chen, SJ; Hsu, WM; Ko, YC; Lau, LI; Lee, FL; Liu, CJ | 1 |
Breusegem, C; Stalmans, I; Van Calster, J; Vandewalle, E; Zeyen, T | 1 |
Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A | 1 |
Amat, P; Lugo, FL; Montero, JA; Ruiz-Moreno, JM | 1 |
Fechtner, RD; Feuer, WJ; Prenner, JL; Realini, T; Roth, DB; Verma, V | 1 |
Callanan, DG; Defaller, J; Robin, AL; Sjaarda, RN; Suan, EP | 1 |
Byun, YS; Park, YH | 1 |
Habot-Wilner, Z; Lightman, S; Sallam, A; Sheth, HG | 1 |
Baser, E; Seymenoglu, R | 1 |
Saatci, AO; Selver, OB; Soylev, MF; Yaman, A | 1 |
Berger, AR; Herschorn, AB; Margolin, EA; Yoganathan, P | 1 |
Hirano, Y; Ito, T; Nozaki, M; Ogura, Y; Sakurai, E; Yasukawa, T; Yoshida, M | 1 |
Borrás, T; Candia, OA; Gerometta, R; Spiga, MG | 1 |
Chan, RP; Chan, WM; Lai, TY; Lam, CP; Lam, DS; Liu, DT; Luk, FO | 1 |
Dubey, S; Gandhi, M; Nazm, N; Pegu, J | 1 |
Chen, HS; Chuang, LH; Ku, WC; Lai, CC; Wang, NK; Yeung, L | 1 |
Ambati, J; Halperin, LS; Kleinman, ME; Pearson, PA; Westhouse, SJ | 1 |
Jonas, JB; Tao, Y | 1 |
Gale, J; Hollands, H; Hollands, S; Seif, G | 1 |
Beck, RW; Bressler, NM; Chew, EY; Ferris, FL; Fish, GE; Glassman, AR; Kinyoun, JL | 1 |
Inoue, M; Ishida, S; Itoh, Y; Kawamura, R; Shinoda, H; Shinoda, K; Tsubota, K | 1 |
Bressler, NM; Edwards, AR; Lauer, AK | 1 |
Gong, Y; Liu, H; Ren, Q; Song, Z; Sun, X | 1 |
Bozkurt, E; Demir, S; Demirok, A; Kara, N; Yazici, AT; Yilmaz, OF; Yuksel, K | 1 |
Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B | 1 |
Chen, H; Cheng, L; Du, W; Li, Y; Lin, B; Liu, X; Sun, S; Zhang, Y | 1 |
Aktas, Z; Deniz, G; Hasanreisoglu, M | 1 |
Balakrishna, N; Mansoori, T; Viswanath, K | 1 |
Cohen, JH; Cohen, SR; Groth, SL; Herro, A; Pollard, J; Singer, MA; Sponsel, WE | 1 |
Bakker, B; den Hollander, AI; Hogewind, BF; Hoyng, CB; Micheal, S | 1 |
Mahar, PS; Memon, AS | 1 |
Chen, FH; Wang, HZ; Wang, RS; Wei, Y; Yang, XG | 1 |
Degenring, R; Jonas, JB; Kreissig, I | 1 |
Adam, R; Bodaghi, B; Bui Quoc, E; Burtin, T; Cassoux, N; Dreifuss, S; Fardeau, C; LeHoang, P | 1 |
Degenring, RF; Jonas, JB; Kreissig, I | 2 |
Degenring, RF; Jonas, JB; Kamppeter, BA | 1 |
Detry-Morel, M; Escarmelle, A; Hermans, I | 1 |
Ahmad, SI; Allingham, RR; Challa, P; Herndon, LW; Lee, PP; Singh, IP; Yeh, D | 1 |
Agrawal, J; Agrawal, S; Agrawal, TP | 3 |
Maranan, L; Ober, MD; Smithen, LM; Spaide, RF | 1 |
Heatley, G; Jonas, J; Spaide, R; Varma, R | 1 |
Vedantham, V | 1 |
Akkoyun, I; Degenring, RF; Jonas, JB; Kamppeter, BA; Kreissig, I | 1 |
Erkiliç, K; Ozkiriş, A | 1 |
Reichle, ML | 1 |
Mennel, S; Meyer, CH; Schmidt, JC | 1 |
Hung, PT; Lin, JM; Tsai, YY | 1 |
Jonas, JB | 1 |
Dhir, L; Prasad, SD | 1 |
Jones, R; Rhee, DJ | 1 |
Belmont, J; Chang, J; Fontanarosa, J; Liu, M; Martidis, A; Moster, MR; Peck, RE; Rhee, DJ | 1 |
Chiu, YT; Hung, PT; Lin, JM; Tsai, YY | 1 |
Ito, T; Nozaki, M; Ogura, Y | 1 |
Kasten-Aker, AG; Nickerson, MM; Pizzimenti, CE; Pizzimenti, JJ | 1 |
Conway, MD | 1 |
Byon, IS; Jea, SY; Oum, BS | 1 |
Budde, WM; Harder, B; Jonas, JB; Kamppeter, BA; Sauder, G; Spandau, UH | 1 |
Chan, CK; Chan, WM; Lai, TY; Lam, DS; Li, KK; Li, PS; Mohamed, S; Shanmugam, MP; Tsang, CW | 1 |
Cano-Parra, J; Díaz-Llopis, M | 1 |
Jonas, JB; Schlichtenbrede, F | 1 |
Aggio, FB; Belfort, R; Belfort, RN; Farah, ME; Lima Filho, AA; Maia, M; Penha, FM | 1 |
Kolluru, C; Krishnadas, R; Mahalakshmi, R; Prasad, NM; Shukla, D; Vidhya, N | 1 |
Chen, SJ; Hsu, WM; Ko, YC; Lau, LI; Lee, FL; Liu, CJ | 1 |
Fukushima, M; Inatani, M; Inomata, Y; Iwao, K; Kawaji, T; Sagara, N; Takano, A; Tanihara, H | 1 |
Fechtner, RD; Feuer, WJ; Gloth, J; Green, SN; Heimmel, MR; Radhakrishnan, R; Realini, T; Roth, DB; Yarian, DL | 1 |
Fukushima, A; Komatsu, T; Koura, Y; Nishino, K; Ueno, H; Yamamoto, Y | 1 |
Hirano, Y; Hirooka, K; Inatani, M; Iwao, K; Kawaji, T; Matsumura, M; Nakanishi, Y; Negi, A; Ogura, Y; Sakamoto, T; Shima, C; Shimonagano, Y; Shiraga, F; Tanihara, H; Yamamoto, H | 1 |
Nehemy, MB; Nehemy, PG; Schachat, AP; Vasconcelos-Santos, DV | 1 |
Cheng, L; Falkenstein, IA; Freeman, WR; Goldbaum, MH; Kayikcioglu, OR; Kozak, I; Tammewar, AM | 1 |
Erie, JC; Kalina, PH; Rosenbaum, L | 1 |
Helm, CJ; Holland, GN | 1 |
Fiscella, RG; Goldstein, DA; Tessler, HH | 1 |
Akduman, L; Black, DL; Del Priore, LV; Kaplan, HJ; Kolker, AE | 1 |
Beaumont, PE; Wingate, RJ | 1 |
Connor, TB; Dev, S; Eastwood, D; George, V; Han, DP; Levin, DS; Mieler, WF; Wirostko, WJ | 1 |
7 review(s) available for triamcinolone acetonide and Ocular Hypertension
Article | Year |
---|---|
[Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
Topics: Acetazolamide; Adrenal Cortex Hormones; Adult; Animals; Child; Delayed-Action Preparations; Dexamethasone; Dose-Response Relationship, Drug; Drug Implants; Filtering Surgery; Fluocinolone Acetonide; Humans; Intravitreal Injections; Ocular Hypertension; Ointments; Ophthalmic Solutions; Rabbits; Retinal Diseases; Risk Factors; Triamcinolone Acetonide | 2015 |
Model systems for the study of steroid-induced IOP elevation.
Topics: Animals; Cell Culture Techniques; Dexamethasone; Disease Models, Animal; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Organ Culture Techniques; Trabecular Meshwork; Triamcinolone Acetonide | 2017 |
Intravitreal triamcinolone.
Topics: Glucocorticoids; Humans; Intravitreal Injections; Ocular Hypertension; Ocular Hypotension; Retinal Diseases; Triamcinolone Acetonide | 2011 |
Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Aged; Antihypertensive Agents; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Ocular Hypertension; Prospective Studies; Retinal Diseases; Risk Factors; Time Factors; Triamcinolone Acetonide; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Topics: Choroidal Neovascularization; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body | 2005 |
Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.
Topics: Choroid Diseases; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Risk Factors; Triamcinolone Acetonide | 2006 |
Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
10 trial(s) available for triamcinolone acetonide and Ocular Hypertension
Article | Year |
---|---|
Effects of intrapolyp steroid injection on intraocular pressure and recurrent polyp treatment.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Prospective Studies; Retrospective Studies; Saline Solution; Triamcinolone Acetonide | 2022 |
The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections.
Topics: Administration, Ophthalmic; Adult; Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide | 2020 |
Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Diabetic Retinopathy; Drug Combinations; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
[Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Topics: Aged; Combined Modality Therapy; Diabetic Retinopathy; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Middle Aged; Ocular Hypertension; Pilot Projects; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2013 |
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Risk Factors; Time Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2015 |
A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes.
Topics: Administration, Topical; Aged; Choroidal Neovascularization; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2010 |
Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
Topics: Aged; Cataract; Cataract Extraction; Combined Modality Therapy; Diabetic Retinopathy; Disease Progression; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Coagulation; Lens, Crystalline; Macular Edema; Middle Aged; Ocular Hypertension; Orbit; Risk Factors; Tenon Capsule; Triamcinolone Acetonide | 2011 |
Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Antihypertensive Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Laser Therapy; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide | 2011 |
[Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Risk Assessment; Risk Factors; Treatment Outcome; Triamcinolone Acetonide | 2005 |
A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
Topics: Aged; Anti-Inflammatory Agents; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
83 other study(ies) available for triamcinolone acetonide and Ocular Hypertension
Article | Year |
---|---|
Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Topics: Aged; Dexamethasone; Drug Implants; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Male; Myopia; Ocular Hypertension; Retrospective Studies; Risk Factors; Triamcinolone Acetonide | 2022 |
Whole-genome sequencing unravels novel genetic determinants and regulatory pathways associated with triamcinolone acetonide-induced ocular hypertension.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; OX40 Ligand; Retrospective Studies; Triamcinolone Acetonide | 2023 |
Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Topics: Dexamethasone; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide | 2023 |
Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Topics: Dexamethasone; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 2020 |
Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Tenon Capsule; Tonometry, Ocular; Triamcinolone Acetonide | 2021 |
Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pseudophakia; Retreatment; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2021 |
OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide; Uveitis, Posterior | 2020 |
Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Female; Glaucoma; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Triamcinolone Acetonide; Turkey; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2013 |
Analyses of Sequence Variants in the MYOC Gene and of Single Nucleotide Polymorphisms in the NR3C1 and FKBP5 Genes in Corticosteroid-Induced Ocular Hypertension.
Topics: Case-Control Studies; Cytoskeletal Proteins; Eye Proteins; Gene Frequency; Genetic Variation; Genotyping Techniques; Glucocorticoids; Glycoproteins; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Ocular Hypertension; Open Reading Frames; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Receptors, Glucocorticoid; Retrospective Studies; Tacrolimus Binding Proteins; Triamcinolone Acetonide | 2015 |
Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Chitosan; Delayed-Action Preparations; Drug Evaluation, Preclinical; Gelatin; Humans; Hydrogels; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Rabbits; Triamcinolone Acetonide | 2014 |
Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
Topics: Adolescent; Adult; Aged; Australia; Child; Dexamethasone; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Intravitreal Injections; Macular Edema; Methylprednisolone; Middle Aged; New Zealand; Ocular Hypertension; Product Surveillance, Postmarketing; Prospective Studies; Retinal Neovascularization; Risk Factors; Surveys and Questionnaires; Tonometry, Ocular; Trabeculectomy; Triamcinolone Acetonide | 2015 |
Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
Topics: Adult; Aged; Device Removal; Drug Implants; Female; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Tenon Capsule; Tonometry, Ocular; Triamcinolone Acetonide | 2016 |
Intraocular Pressure after Intravitreal Triesence Injection.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Triamcinolone Acetonide | 2018 |
Bevacizumab and Panretinal photocoagulation protect against ocular hypertension after posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Topics: Adult; Aged; Aged, 80 and over; Bevacizumab; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Light Coagulation; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 2017 |
UK national survey of current practice and experience of intravitreal triamcinolone acetonide.
Topics: Anti-Inflammatory Agents; Eye Diseases; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Practice Patterns, Physicians'; Surveys and Questionnaires; Triamcinolone Acetonide; United Kingdom | 2009 |
Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population.
Topics: Adult; Age Factors; Aged; Asian People; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prevalence; Retrospective Studies; Risk Factors; Sex Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2008 |
Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Confidence Intervals; Dexamethasone; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; False Positive Reactions; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Predictive Value of Tests; Prospective Studies; Retinal Vein Occlusion; Sensitivity and Specificity; Telangiectasis; Triamcinolone Acetonide | 2009 |
[Intravitreous injection: retrospective study on 2028 injections and their side effects].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage | 2008 |
Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Cataract Extraction; Choroidal Neovascularization; Combined Modality Therapy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2009 |
Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Topics: Aged; Antihypertensive Agents; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Male; Ocular Hypertension; Retinal Diseases; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Triamcinolone Acetonide; Vitreous Body | 2009 |
Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Delayed-Action Preparations; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Pregnadienediols; Prospective Studies; Retinal Diseases; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2009 |
Complications and safety profile of posterior subtenon injection of triamcinolone acetonide.
Topics: Cataract; Disease Progression; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 2009 |
Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chronic Disease; Female; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prednisolone; Prostaglandins F, Synthetic; Retrospective Studies; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Young Adult | 2009 |
Selective laser trabeculoplasty for the treatment of intraocular pressure elevation after intravitreal triamcinolone injection.
Topics: Adult; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Ocular Hypertension; Trabeculectomy; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2009 |
Letter: Visual acuity improvement in acute non-arteritic anterior ischaemic optic neuropathy treated with intravitreal triamcinolone acetonide injection.
Topics: Acute Disease; Glucocorticoids; Humans; Injections; Intraocular Pressure; Ocular Hypertension; Optic Neuropathy, Ischemic; Triamcinolone Acetonide; Visual Acuity | 2009 |
Inadvertent subretinal triamcinolone injection in a case of recurrent scleritis.
Topics: Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Middle Aged; Needlestick Injuries; Ocular Hypertension; Recurrence; Retina; Sclera; Scleritis; Triamcinolone Acetonide; Visual Acuity | 2009 |
Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Administration Routes; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Risk Factors; Tonometry, Ocular; Trabeculectomy; Triamcinolone Acetonide | 2009 |
Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus.
Topics: Adenoviridae; Animals; Anterior Chamber; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Genetic Therapy; Genetic Vectors; Glucocorticoids; Intraocular Pressure; Matrix Metalloproteinase 1; Ocular Hypertension; Prednisolone; Sheep; Tonometry, Ocular; Triamcinolone Acetonide | 2010 |
Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy.
Topics: Aged; Cataract; Choroid; Choroid Diseases; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ocular Hypertension; Peripheral Vascular Diseases; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Vision Disorders; Visual Acuity | 2010 |
Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Topics: Acute Disease; Antihypertensive Agents; Chronic Disease; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Prednisolone; Prostaglandins F, Synthetic; Tonometry, Ocular; Triamcinolone Acetonide; Uveitis | 2010 |
Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2010 |
Triamcinolone crystal size.
Topics: Crystallization; Drug Compounding; Glucocorticoids; Humans; Intraocular Pressure; Microscopy, Phase-Contrast; Ocular Hypertension; Off-Label Use; Particle Size; Preservatives, Pharmaceutical; Triamcinolone Acetonide; Vitreous Body | 2010 |
Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Monitoring; Female; Glucocorticoids; Humans; Incidence; Injections, Intraocular; Intraocular Pressure; Japan; Male; Medical Records; Middle Aged; Ocular Hypertension; Refractive Errors; Retinal Diseases; Retrospective Studies; Tenon Capsule; Time Factors; Triamcinolone Acetonide | 2011 |
Frequency of intraocular pressure increase within days after intravitreal triamcinolone injections in the diabetic retinopathy clinical research network.
Topics: Diabetic Retinopathy; Humans; Intraocular Pressure; Intravitreal Injections; Ocular Hypertension; Randomized Controlled Trials as Topic; Time Factors; Triamcinolone Acetonide | 2011 |
Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits.
Topics: Administration, Oral; Animals; Aqueous Humor; Electroretinography; Follow-Up Studies; Glaucoma; Glycyrrhizic Acid; Humans; Intraocular Pressure; Intravitreal Injections; Magnetic Resonance Spectroscopy; Male; Ocular Hypertension; Principal Component Analysis; Rabbits; Retina; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2011 |
[Complications of intravitreal injections--own experience].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 2011 |
Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study.
Topics: Female; Glucocorticoids; Humans; Incidence; Injections, Intraocular; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Tenon Capsule; Triamcinolone Acetonide; Visual Acuity | 2012 |
Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Female; Glucocorticoids; Humans; Intraocular Pressure; Laser Therapy; Male; Ocular Hypertension; Trabeculectomy; Triamcinolone Acetonide | 2012 |
Incidence and risk factors for secondary ocular hypertension after intravitreal triamcinolone acetonide injection in Asian Indian eyes.
Topics: Adult; Aged; Antihypertensive Agents; Asian People; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2013 |
Association of OCT angle recess width with IOP response after intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Tonometry, Ocular; Triamcinolone Acetonide; Young Adult | 2013 |
Analysis of single nucleotide polymorphisms in the SFRS3 and FKBP4 genes in corticosteroid-induced ocular hypertension.
Topics: Aged; Case-Control Studies; Female; Gene Frequency; Genotype; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Retrospective Studies; RNA-Binding Proteins; Serine-Arginine Splicing Factors; Tacrolimus Binding Proteins; Tonometry, Ocular; Triamcinolone Acetonide | 2012 |
Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Eye Diseases; Female; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Pakistan; Prospective Studies; Risk Factors; Time Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2012 |
Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Topics: Aged; Anti-Inflammatory Agents; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Tonometry, Ocular; Triamcinolone Acetonide | 2012 |
Intraocular pressure after intravitreal injection of triamcinolone acetonide.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Triamcinolone Acetonide; Vitreous Body | 2003 |
[Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Child; Female; Humans; Injections; Male; Middle Aged; Ocular Hypertension; Triamcinolone Acetonide; Uveitis | 2002 |
[Intraocular triamcinolone for diffuse diabetic macular edema].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macula Lutea; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Prospective Studies; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2004 |
Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide.
Topics: Diabetic Retinopathy; Female; Humans; Injections; Macular Edema; Middle Aged; Ocular Hypertension; Pseudophakia; Remission Induction; Sclera; Triamcinolone Acetonide; Visual Acuity | 2004 |
Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.
Topics: Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2004 |
Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
Topics: Drainage; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2004 |
Intravitreal triamcinolone acetonide and intraocular pressure.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body | 2004 |
Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
Topics: Glucocorticoids; Humans; Injections; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide | 2005 |
Intravitreal triamcinolone acetonide and secondary ocular hypertension.
Topics: Aged; Antihypertensive Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intraocular pressure rise after intravitreal triamcinolone.
Topics: Glucocorticoids; Humans; Injections; Intraocular Pressure; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body | 2005 |
Complications of intravitreal injection of triamcinolone acetonide.
Topics: Cataract; Cataract Extraction; Disease Progression; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2005 |
Complications of intravitreal steroid injections.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Choroidal Neovascularization; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Ocular Hypertension; Photochemotherapy; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Intravitreal triamcinolone acetonide may increase the intraocular pressure even in vitrectomized eyes after more than 3 months.
Topics: Glucocorticoids; Humans; Injections; Intraocular Pressure; Ocular Hypertension; Time Factors; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2005 |
IOP after triamcinolone acetonide.
Topics: Filtering Surgery; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Triamcinolone Acetonide; Vitrectomy | 2005 |
Intravitreal triamcinolone and IOP.
Topics: Antihypertensive Agents; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Triamcinolone Acetonide | 2006 |
IOP after triamcinolone acetonide.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Time Factors; Triamcinolone Acetonide | 2006 |
Intraocular pressure alterations following intravitreal triamcinolone acetonide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antihypertensive Agents; Drug Administration Schedule; Female; Glaucoma; Glucocorticoids; Humans; Injections; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Survival Analysis; Triamcinolone Acetonide; Vitreous Body | 2006 |
Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity?
Topics: Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Ocular Hypertension; Paracentesis; Triamcinolone Acetonide; Vitreous Body | 2006 |
[Incidence and risk factors of intraocular pressure elevation after triamcinolone acetonide administration for macular disorders].
Topics: Age Factors; Aged; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Middle Aged; Myopia; Ocular Hypertension; Risk Factors; Triamcinolone Acetonide; Vitrectomy | 2006 |
Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Macular Edema; Male; Middle Aged; Ocular Hypertension; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2006 |
The problem of pressure elevation associated with intravitreal triamcinolone.
Topics: Anti-Inflammatory Agents; Glucocorticoids; Humans; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body | 2006 |
Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Orbit; Retrospective Studies; Time Factors; Triamcinolone Acetonide; Uveitis, Posterior; Vitreous Body | 2006 |
Triamcinolone acetonide-induced ocular hypertension.
Topics: Adult; Antihypertensive Agents; Diagnostic Techniques, Ophthalmological; Female; Glucocorticoids; Humans; Intraocular Pressure; Lasers; Nerve Fibers; Ocular Hypertension; Optic Disk; Optic Nerve Diseases; Tomography; Triamcinolone Acetonide; Uveitis | 2006 |
[New drugs in the treatment of noninfectious uveitis].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Clinical Trials as Topic; Daclizumab; Fluocinolone Acetonide; Humans; Immunoglobulin G; Infliximab; Injections; Ocular Hypertension; Triamcinolone Acetonide; Uveitis; Vitreous Body | 2006 |
Effects of intravitreal triamcinolone acetonide injection with and without preservative.
Topics: Adult; Aged; Aged, 80 and over; Drug Evaluation; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2007 |
Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body | 2007 |
Laser trabeculoplasty.
Topics: Adult; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Retinal Diseases; Trabecular Meshwork; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Cataract; Disease Progression; Drug Evaluation; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
Short-term complications of intravitreal injection of triamcinolone acetonide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Choroid Diseases; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Topics: Age Factors; Connective Tissue; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Sex Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Topics: Aged; Case-Control Studies; Connective Tissue; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2008 |
Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2008 |
Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections.
Topics: Anti-Inflammatory Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Multivariate Analysis; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy | 2008 |
Biochemical quantification of triamcinolone in subconjunctival depots.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Conjunctiva; Delayed-Action Preparations; Female; Glaucoma; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Triamcinolone Acetonide | 1995 |
The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.
Topics: Adolescent; Adult; Aged; Child; Fascia; Female; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Orbit; Postoperative Complications; Triamcinolone Acetonide; Uveitis, Intermediate; Vision Disorders; Visual Acuity | 1995 |
Biochemical quantification of triamcinolone in subconjunctival depots.
Topics: Anti-Inflammatory Agents; Conjunctiva; Delayed-Action Preparations; Humans; Intraocular Pressure; Ocular Hypertension; Triamcinolone Acetonide | 1996 |
Treatment of persistent glaucoma secondary to periocular corticosteroids.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Child; Fasciotomy; Glaucoma; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Orbit; Triamcinolone Acetonide; Uveitis | 1996 |
Intravitreal triamcinolone and elevated intraocular pressure.
Topics: Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Ocular Hypertension; Prospective Studies; Retinal Neovascularization; Risk Factors; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 1999 |
Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation.
Topics: Adult; Aged; Aged, 80 and over; Connective Tissue; Contraindications; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Methylprednisolone Hemisuccinate; Middle Aged; Ocular Hypertension; Recurrence; Retrospective Studies; Risk Factors; Triamcinolone; Triamcinolone Acetonide | 2002 |